Continuous glucose monitoring in ICU patients
Part of Hormones & metabolism clinical trials.
This study looks at how well continuous glucose monitors (small sensors under the skin that track sugar levels) work in ICU patients who need insulin. If you are in the ICU, on insulin, and already have a sensor, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being treated in the Intensive Care Unit
- You are receiving insulin right now
- You have a continuous glucose monitor sensor placed on your body
- You or your family member can sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a continuous glucose monitoring system for people in the intensive care unit (ICU). It checks how well the device measures blood sugar and if it can help predict outcomes for critically ill patients.
This trial tests using a continuous glucose monitor to track blood sugar levels in intensive care patients. The monitor sends readings wirelessly, which may help doctors adjust insulin more quickly and safely.
This trial checks whether a continuous glucose monitoring system (“CGM GUARDIAN 2”) can be used safely and effectively for people in the ICU who have septic shock and high blood sugar. It may help the medical team track blood sugar more easily while you receive insulin.
This study tests whether a small continuous glucose monitor (a sensor that checks your sugar levels all the time) can be used easily in youth who are in the hospital. It may help doctors track your blood sugar closely without needing as many finger sticks.
This study tests if a continuous glucose monitor (CGM) can help guide insulin drip therapy for non-ICU patients who are on steroids and specialized nutrition. It aims to make insulin management easier and more accurate for patients with diabetes or high blood sugar during hospitalization.
This study compares a continuous glucose monitor (a small sensor on the skin) with the usual fingerstick method for checking blood sugar in hospitalized patients. It aims to see if the sensor is more convenient and just as accurate.
Hear when a new Hyperglycemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.